COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
31 12 2022
Historique:
pubmed: 7 7 2021
medline: 16 3 2022
entrez: 6 7 2021
Statut: ppublish

Résumé

With unprecedented speed, multiple vaccines against SARS-CoV-2 are available 1 year after the COVID-19 pandemic was first identified. As we push to achieve global control through these new vaccines, old challenges present themselves, including cold-chain storage, the logistics of mass vaccination, and vaccine hesitancy. Understanding how much hesitancy toward COVID-19 vaccines might occur and what factors may be driving these concerns can improve the ability of public health workers and communicators to maximize vaccine uptake. We nested a survey within a measles-rubella mass vaccination campaign in Zambia in November 2020 and asked about sentiments and beliefs toward COVID-19 and COVID-19 vaccines. Among parents bringing their children to receive a measles-rubella vaccine, we found high acceptability of COVID-19 vaccination of their children, but substantial uncertainty and hesitancy about receiving the vaccine themselves. COVID-19 vaccination hesitancy was correlated with beliefs around COVID-19 severity and risk, as well as vaccine safety and effectiveness.

Identifiants

pubmed: 34227914
doi: 10.1080/21645515.2021.1948784
pmc: PMC8920139
doi:

Substances chimiques

COVID-19 Vaccines 0
Measles Vaccine 0
Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-6

Références

Vaccine. 2021 Mar 12;39(11):1556-1564
pubmed: 33618947
Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Pers Individ Dif. 2021 Apr;172:110590
pubmed: 33518869
R Soc Open Sci. 2020 Sep 16;7(9):200742
pubmed: 33047037
Bull World Health Organ. 2018 Feb 01;96(2):86-93
pubmed: 29403111
Vaccine. 2017 Sep 5;35(37):4840-4850
pubmed: 28760616
Front Psychol. 2020 Sep 30;11:551004
pubmed: 33117223
Soc Sci Med. 2021 Mar;272:113688
pubmed: 33485215
Soc Sci Med. 2019 Nov;240:112552
pubmed: 31561111
Vaccine. 2018 Nov 29;36(50):7666-7673
pubmed: 30391054
MMWR Morb Mortal Wkly Rep. 2020 May 01;69(17):515-520
pubmed: 32352953
R Soc Open Sci. 2020 Oct 14;7(10):201199
pubmed: 33204475
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33097547
Vaccine. 2020 Nov 10;38(48):7668-7673
pubmed: 33071002
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73
pubmed: 23584253
Health Promot J Austr. 2019 Apr;30(2):143-152
pubmed: 30091836

Auteurs

Andrea C Carcelen (AC)

Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Christine Prosperi (C)

Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Simon Mutembo (S)

Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Laboratory Science, Macha Research Trust, Choma, Zambia.

Gershom Chongwe (G)

Department of Immunology, Tropical Diseases Research Center, Ndola, Zambia.

Francis D Mwansa (FD)

Ministry of the Health, Government of the Republic of Zambia, Lusaka, Zambia.

Phillimon Ndubani (P)

Laboratory Science, Macha Research Trust, Choma, Zambia.

Edgar Simulundu (E)

Laboratory Science, Macha Research Trust, Choma, Zambia.

Innocent Chilumba (I)

Department of Immunology, Tropical Diseases Research Center, Ndola, Zambia.

Gloria Musukwa (G)

Laboratory Science, Macha Research Trust, Choma, Zambia.

Phil Thuma (P)

Laboratory Science, Macha Research Trust, Choma, Zambia.

Kelvin Kapungu (K)

Department of Immunology, Tropical Diseases Research Center, Ndola, Zambia.

Mutinta Hamahuwa (M)

Laboratory Science, Macha Research Trust, Choma, Zambia.

Irene Mutale (I)

Department of Immunology, Tropical Diseases Research Center, Ndola, Zambia.

Amy Winter (A)

Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

William J Moss (WJ)

Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
W Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Shaun A Truelove (SA)

Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH